If you could vote on Brexit now which option would you choose?
   

JPM: 'Very soon,' says Johnson & Johnson CEO as world waits for its COVID-19 vaccine data


Johnson & Johnson's one-dose COVID-19 vaccine regimen could jump-start an immunization push that's faltering in spite of the millions of doses Pfizer, BioNTech, AstraZeneca and Moderna are rolling out around the world. And the J&J shot is on the verge of its next big step forward. The pharma giant is in the “final stages” of data analysis for its phase 3 trial, CEO Alex Gorsky said Monday at the annual J.P. Morgan healthcare conference. The company hopes “to have that information very soon,” he added.

FiercePharma - January 12, 2021

View the full story here: https://www.fiercepharma.com/pharma/jpm-j-j-hopes-to-share-phase-3-coronavirus-vaccine-data-very-soon-ceo-says